180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibro...
Restart Life Sciences Strengthens Operational Infrastructure to Scale "Better-for-You" Portfolio | NMLSF Stock News
Restart Life Sciences Appoints Capital Markets Veteran Lindsay Hamelin to Board of Directors | NMLSF Stock News
Restart Life Sciences Reports Holy Crap Foods Revenue Gains of 46% in Wholesale and 32% via Amazon Channels YoY | NMLSF Stock News
Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio | NMLSF Stock News
LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc. | BBCMF Stock News
Restart Life Leverages Certified Plant to Scale Functional Wellness Brands